2023
DOI: 10.3831/kpi.2023.26.2.192
|View full text |Cite
|
Sign up to set email alerts
|

External Treatment of Pyritum for Musculoskeletal Trauma: a protocol for systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…[ 9 ] In Korea, there have been many studies on pyritum manufacturing technology or animal experiments, but it was not easy to find relevant clinical literature. [ 2 , 3 , 10 ] Pyritum was used clinically in China through Chinese patented medicine (CPM) containing pyritum or decoction with other herbal materials rather than alone in clinical practice. CPM is a drug approved by the China Food and Drug Administration Law of the People’s Republic of China and the Provision, processed into a fixed dosage form through a standardized procedure.…”
Section: Introductionmentioning
confidence: 99%
“…[ 9 ] In Korea, there have been many studies on pyritum manufacturing technology or animal experiments, but it was not easy to find relevant clinical literature. [ 2 , 3 , 10 ] Pyritum was used clinically in China through Chinese patented medicine (CPM) containing pyritum or decoction with other herbal materials rather than alone in clinical practice. CPM is a drug approved by the China Food and Drug Administration Law of the People’s Republic of China and the Provision, processed into a fixed dosage form through a standardized procedure.…”
Section: Introductionmentioning
confidence: 99%